These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 2710173)
1. Effect of the time of administration of calcium acetate on phosphorus binding. Schiller LR; Santa Ana CA; Sheikh MS; Emmett M; Fordtran JS N Engl J Med; 1989 Apr; 320(17):1110-3. PubMed ID: 2710173 [TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
3. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients. Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523 [TBL] [Abstract][Full Text] [Related]
4. Calcium acetate versus calcium carbonate as phosphorus binders in patients on chronic haemodialysis: a controlled study. Ring T; Nielsen C; Andersen SP; Behrens JK; Sodemann B; Kornerup HJ Nephrol Dial Transplant; 1993; 8(4):341-6. PubMed ID: 8390009 [TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal absorption of calcium from milk and calcium salts. Sheikh MS; Santa Ana CA; Nicar MJ; Schiller LR; Fordtran JS N Engl J Med; 1987 Aug; 317(9):532-6. PubMed ID: 3614304 [TBL] [Abstract][Full Text] [Related]
6. Calcium acetate, an effective phosphorus binder in patients with renal failure. Mai ML; Emmett M; Sheikh MS; Santa Ana CA; Schiller L; Fordtran JS Kidney Int; 1989 Oct; 36(4):690-5. PubMed ID: 2811066 [TBL] [Abstract][Full Text] [Related]
7. Calcium and phosphorus metabolism in nephrotic syndrome. Lim P; Jacob E; Tock EP; Pwee HS Q J Med; 1977 Jul; 46(183):327-38. PubMed ID: 303365 [TBL] [Abstract][Full Text] [Related]
8. Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate. Sebastian A; Harris ST; Ottaway JH; Todd KM; Morris RC N Engl J Med; 1994 Jun; 330(25):1776-81. PubMed ID: 8190153 [TBL] [Abstract][Full Text] [Related]
9. Sevelamer reduces calcium load and maintains a low calcium-phosphorus ion product in dialysis patients. Gallieni M; Cozzolino M; Carpani P; Zoni U; Brancaccio D J Nephrol; 2001; 14(3):176-83. PubMed ID: 11439741 [TBL] [Abstract][Full Text] [Related]
10. Calcium load during administration of calcium carbonate or sevelamer in individuals with normal renal function. Heinrich T; Heidt H; Hafner V; Schmidt-Gayk H; Jenetzky E; Walter-Sack I; Mikus G; Bommer J Nephrol Dial Transplant; 2008 Sep; 23(9):2861-7. PubMed ID: 18388122 [TBL] [Abstract][Full Text] [Related]
11. Calcium and inorganic phosphorus metabolism in naked mole rats Heterocephalus glaber is only indirectly affected by cholecalciferol. Yahav S; Buffenstein R; Pettifor JM Gen Comp Endocrinol; 1993 Jan; 89(1):161-6. PubMed ID: 8381370 [TBL] [Abstract][Full Text] [Related]
12. Does concomitant administration of sevelamer and calcium carbonate modify the control of phosphatemia? Ouellet G; Cardinal H; Mailhot M; Ste-Marie LG; Roy L Ther Apher Dial; 2010 Apr; 14(2):172-7. PubMed ID: 20438539 [TBL] [Abstract][Full Text] [Related]
13. Aluminum hydroxide: evaluation of two dosage forms and two dosing schedules in reducing intestinal phosphate absorption. Smith DR; Chang BS; Johnson CE Am J Hosp Pharm; 1978 Jan; 35(1):58-61. PubMed ID: 623119 [TBL] [Abstract][Full Text] [Related]
14. Results of a randomized crossover study comparing once-daily and thrice-daily sevelamer dosing. Fischer D; Cline K; Plone MA; Dillon M; Burke SK; Blair AT Am J Kidney Dis; 2006 Sep; 48(3):437-44. PubMed ID: 16931217 [TBL] [Abstract][Full Text] [Related]
15. Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study. Sheikh MS; Maguire JA; Emmett M; Santa Ana CA; Nicar MJ; Schiller LR; Fordtran JS J Clin Invest; 1989 Jan; 83(1):66-73. PubMed ID: 2910921 [TBL] [Abstract][Full Text] [Related]
16. RenaGel, a novel calcium- and aluminium-free phosphate binder, inhibits phosphate absorption in normal volunteers. Burke SK; Slatopolsky EA; Goldberg DI Nephrol Dial Transplant; 1997 Aug; 12(8):1640-4. PubMed ID: 9269642 [TBL] [Abstract][Full Text] [Related]